130 related articles for article (PubMed ID: 24377580)
21. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery.
Castle SM; Gorbatiy V; Ekwenna O; Young E; Leveillee RJ
BJU Int; 2012 Feb; 109(3):384-7. PubMed ID: 22176671
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
23. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.
Ramirez D; Ma YB; Bedir S; Antonelli JA; Cadeddu JA; Gahan JC
J Endourol; 2014 Mar; 28(3):330-4. PubMed ID: 24156661
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
26. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation--incidence and clinical importance in 101 consecutive patients.
Schirmang TC; Mayo-Smith WW; Dupuy DE; Beland MD; Grand DJ
Radiology; 2009 Oct; 253(1):263-9. PubMed ID: 19703853
[TBL] [Abstract][Full Text] [Related]
27. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
del Cura JL; Zabala R; Iriarte JI; Unda M
Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors for complete renal tumor ablation using RFA.
Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous radiofrequency ablation of renal cell carcinoma.
Chiou YY; Hwang JI; Chou YH; Wang JH; Chiang JH; Chang CY
J Chin Med Assoc; 2005 May; 68(5):221-5. PubMed ID: 15909727
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique?
Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J
Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801
[TBL] [Abstract][Full Text] [Related]
31. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
33. Treatment Failure After Image-Guided Percutaneous Radiofrequency Ablation (RFA) of Renal Tumors - A Systematic Review with Description of Type, Frequency, Risk Factors and Management.
Vollherbst D; Bertheau R; Kauczor HU; Radeleff BA; Pereira PL; Sommer CM
Rofo; 2017 Mar; 189(3):219-227. PubMed ID: 27627446
[No Abstract] [Full Text] [Related]
34. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring.
Wingo MS; Leveillee RJ
J Endourol; 2008 Jun; 22(6):1261-7. PubMed ID: 18484892
[TBL] [Abstract][Full Text] [Related]
35. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
36. [Percutaneous radiofrequency ablation of the renal tumors. Initial clinical experience with minimally invasive therapy].
Hoffmann P; Dvorák P; Morávek P; Safránek H
Rozhl Chir; 2007 Sep; 86(9):494-9. PubMed ID: 17974143
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.
Svatek RS; Sims R; Anderson JK; Abdel-Aziz K; Cadeddu JA
Urology; 2006 Mar; 67(3):508-12. PubMed ID: 16504265
[TBL] [Abstract][Full Text] [Related]
38. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
39. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
[TBL] [Abstract][Full Text] [Related]
40. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
Urology; 2005 May; 65(5):877-81. PubMed ID: 15882715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
